Pacer Advisors
IRON icon

Pacer Advisors’s Disc Medicine IRON Stock Holding History

Pacer Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Buy
+444
New +$30.5K ﹤0.01% 2148
2024
Q3 		– Sell
-136
Closed -$6.13K – 2624
2024
Q2 		$6.13K Sell
136
-341
-71% -$11.6K ﹤0.01% 3619
2024
Q1 		$29.7K Buy
+477
New +$30.9K ﹤0.01% 3363

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pacer Advisors's IRON Position: Q2 2026 in Review

Pacer Advisors opened a new position in Disc Medicine (IRON) in Q2 2026: 444 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #2148 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in IRON as recently as Q2 2024.

Pacer Advisors first reported a position in IRON in Q1 2024 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Pacer Advisors held 444 shares of Disc Medicine worth $32K as of Q2 2026.
  • Disc Medicine was a new Pacer Advisors position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2148 holding.
  • Pacer Advisors first reported a position in Disc Medicine in Q1 2024 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.